Qube Research & Technologies (QRT)’s Cymabay Therapeutics CBAY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-132,809	Closed	-$3.14M	–	4988
2023 Q4	$3.14M	Buy	+132,809	New	+$2.37M	0.01%	1301
2023 Q2	–	Sell	-19,687	Closed	-$172K	–	3168
2023 Q1	$172K	Sell	19,687 -72,418	-79%	-$580K	﹤0.01%	1985
2022 Q4	$577K	Buy	92,105 +32,081	+53%	+$122K	﹤0.01%	1428
2022 Q3	$210K	Buy	60,024 +41,862	+230%	+$150K	﹤0.01%	1760
2022 Q2	$54K	Buy	+18,162	New	+$43.4K	﹤0.01%	2106
2021 Q1	–	Sell	-22,658	Closed	-$130K	–	2525
2020 Q4	$130K	Sell	22,658 -39,919	-64%	-$302K	﹤0.01%	1610
2020 Q3	$453K	Buy	62,577 +52,394	+515%	+$280K	0.01%	1081
2020 Q2	$36K	Buy	+10,183	New	+$29.4K	﹤0.01%	1633

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CBAY Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 132,809 shares — an estimated $3.14M sold.

Qube Research & Technologies (QRT) first reported a position in CBAY in Q2 2020 and held it in 8 quarters. The position peaked at $3.14M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Qube Research & Technologies (QRT) reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 132,809 Cymabay Therapeutics shares in Q1 2024, an estimated $3.14M.
Qube Research & Technologies (QRT) first reported a position in Cymabay Therapeutics in Q2 2020 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s Cymabay Therapeutics position peaked at $3.14M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.